会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Synthesis of hGRF (Somatocrinin) in liquid phase and intermediate
peptides
    • 在液相和中间肽中合成hGRF(somatocrinin)
    • US4797469A
    • 1989-01-10
    • US87892
    • 1987-08-21
    • Joseph DiazHenri DemarneRomeo RoncucciPaul-Henry Schmelck
    • Joseph DiazHenri DemarneRomeo RoncucciPaul-Henry Schmelck
    • C07K5/04A61K38/00A61K38/04A61K38/22C07K7/06C07K7/08C07K14/00C07K14/575C07K14/60C07K7/10C07K5/10
    • C07K14/60A61K38/00Y10S930/12
    • A process for the synthesis, in liquid phase and by fragments, of hGRF 1-44 and hGRF 1-40. This process consists in coupling, one after the other and in the order of the sequence of the GRF,(1) on the one hand, the following fragments:__________________________________________________________________________H--Ala--Arg--Ala--Arg--Leu--NH.sub.2 called Fragment A hGRF (40-44) or alaninamide (40) H--Gln--Glu--Arg--Gly--OH called Fragment B'.sub.1 hGRF (36-39) H--Glu--Ser--Asn--OH called Fragment B'.sub.2 hGRF (33-35) H--Ser--Arg--Gln--Gln--Gly--OH called Fragment C hGRF (28-32) H--Leu--Gln--Asp--Ile--Met--OH called Fragment D' hGRF (23-27) H--Arg--Lys--Leu--OH called Fragment E'.sub.1 hGRF (20-22) __________________________________________________________________________to obtain the peptide K.sub.1 [(hGRF (20-44)] on the corresponding peptide having the sequence (20-40) and(2) on the other hand, the following fragments:__________________________________________________________________________H--Gln--Leu--Ser--Ala called Fragment F.sub.1 hGRF (16-19) H--Tyr--Arg--Lys--Val--Leu--Gly OH called Fragment G.sub.1 hGRF (10-15) H--Ile--Phe--Thr--Asn--Ser--OH called Fragment H.sub.1 hGRF (5-9) __________________________________________________________________________to obtain the peptide J [hGRF (5-19)] and thereafter to couple together the peptides J and K.sub.1 in order to form the peptide having the sequence hGRF (5-44) or hGRF (5-40) and finally to couple the resulting peptide with the peptide H-Tyr-Ala-Asp-Ala-OH, called fragment I hGRF (1-4).
    • 用于合成hGRF 1-44和hGRF 1-40的液相和碎片的方法。 该方法一个接一个地并且按照GRF的序列顺序偶联,(1)一方面是以下片段:称为片段A的-H-Ala-Arg-Ala-Arg-Leu-NH2 称为片段B'1 hGRF(36-39)-H-Glu-Ser-Asn-OH的片段B'2(40-44)或 - 丙氨酰胺(40)-H-Gln-Glu-Arg-Gly-OH 称为片段C hGRF(28-32)-H-Leu-Gln-Asp-Ile-Met-OH的称为片段D'hGRF(23-35)的hGRF(33-35)-H-Ser-Arg-Gln-Gln-Gly-OH -27)-H-Arg-Lys-Leu-OH称为片段E'1 hGRF(20-22) - 获得具有序列(20-40)的相应肽上的肽K1 [(hGRF(20-44)] )和(2)另一方面,以下片段:称为片段F1的h-Gln-Leu-Ser-Ala hGRF(16-19)-H-Tyr-Arg-Lys-Val-Leu-Gly OH称为片段 称为片段H1 hGRF(5-9)的G1 hGRF(10-15)-H-Ile-Phe-Thr-Asn-Ser-OH,以获得肽J [hGRF(5-19)],然后将 肽J和K1以形成具有序列hGRF(5-44)或hGRF(5-40)的肽和最终的 将所得肽与肽H-Tyr-Ala-Asp-Ala-OH(称为片段I hGRF(1-4))偶联。
    • 4. 发明授权
    • Synthesis of hGRF (somatocrinin) in liquid phase and intermediate
peptides
    • 在液相和中间体肽中合成hGRF(somatocrinin)
    • US4707541A
    • 1987-11-17
    • US752799
    • 1985-07-08
    • Joseph DiazHenri DemarneRomeo RoncucciPaul-Henry Schmelck
    • Joseph DiazHenri DemarneRomeo RoncucciPaul-Henry Schmelck
    • C07K5/04A61K38/00A61K38/04A61K38/22C07K7/06C07K7/08C07K14/00C07K14/575C07K14/60C07K7/10
    • C07K14/60A61K38/00Y10S930/12
    • A process for the synthesis, in liquid phase and by fragments, of hGRF 1-44 and hGRF 1-40. This process consists in coupling, one after the other and in the order of the sequence of the GRF,(1) on the one hand, the following fragments:______________________________________ H--Ala--Arg--Ala--Arg--Leu--NH.sub.2 called hGRF Frag- (40-44) or ment A alaninamide (40) H--Gln--Glu--Arg--Gly--OH called hGRF Frag- (36-39) ment B'.sub.1 H--Glu--Ser--Asn--OH called hGRF Frag- (33-35) ment B'.sub.2 H--Ser--Arg--Gln--Gln--Gly--OH called hGRF Frag- (28-32) ment C H--Leu--Gln--Asp--Ile--Met--OH called hGRF Frag- (23-27) ment D' H--Arg--Lys--Leu--OH called hGRF Frag- (20-22) ment E'.sub.1 ______________________________________ to obtain the peptide K.sub.1 [(hGRF (20-44)] on the corresponding peptide having the sequence (20-40) and(2) on the other hand, the following fragments:______________________________________ H--Gln--Leu--Ser--Ala called hGRF Frag- (16-19) ment F.sub.1 H--Tyr--Arg--Lys--Val--Leu--Gly OH called hGRF Frag- (10-15) ment G.sub.1 H--Ile--Phe--Thr--Asn--Ser--OH called hGRF Frag- (5-9) ment H.sub.1 ______________________________________ to obtain the peptide J [hGRF (5-19)] and thereafter to couple together the peptides J and K.sub.1 in order to form the peptide having the sequence hGRF (5-44) or hGRF (5-40) and finally to couple the resulting peptide with the peptide H-Tyr-Ala-Asp-Ala-H, called fragment I hGRF (1-4).
    • 用于合成hGRF 1-44和hGRF 1-40的液相和碎片的方法。 该方法一个接一个地并且按照GRF序列的顺序偶联,(1)一方面是以下片段:称为hGRF的-H-Ala-Arg-Ala-Arg-Leu-NH2 - Frag-(40-44)或称为丙氨酰胺 - (40)-H-Gln-Glu-Arg-Gly-OH称为hGRF-Frag-(36-39)B'1-Glu-Ser- Asn-OH称为hGRF - Frag-(33-35) - 称为hGRF-Frag-(28-32)C -H-Leu-的B'2 -H-Ser-Arg-Gln-Gln-Gly-OH 称为hGRF-Frag-(23-27)的Gln-Asp-Ile-Met-OH称为hGRF-Frag-(20-22)E'1至D'-H-Arg-Lys-Leu-OH 另一方面,获得具有序列(20-40)和(2)的相应肽上的肽K1 [(hGRF(20-44)],以下片段:称为hGRF的-H-Gln-Leu-Ser-Ala 被称为hGRF-Frag-(10-15)的G1-Ile-Phe-Thr-Asn-的Frag-(16-19)F1 -H-Tyr-Arg-Lys-Val-Leu-Gly OH Ser-OH称为hGRF-Frag-(5-9) - H1以获得肽J [hGRF(5-19)],然后将肽J和K1偶联以形成肽ha v序列hGRF(5-44)或hGRF(5-40),最后将所得肽与肽H-Tyr-Ala-Asp-Ala-H(称为片段I hGRF(1-4))偶联。
    • 8. 发明授权
    • Fluid displacement apparatus with improved helical rotor structure
    • 具有改进的螺旋转子结构的流体位移装置
    • US06244844B1
    • 2001-06-12
    • US09283118
    • 1999-03-31
    • Daniel Joseph Diaz
    • Daniel Joseph Diaz
    • F03C200
    • F01C1/084
    • A fluid displacement apparatus includes a housing defining a chamber therein having a first port and a second port. First and second helical rotors with opposing pitches are meshed within the chamber, in fluid communication with the first and second ports. A respective one of the first and second helical rotors includes a cylindrical body portion having a helical groove therein and a helical tooth portion extending radially from the cylindrical body portion adjacent the helical groove. The first and second helical rotors are arranged such that respective longitudinal axes of the first and second helical rotors are parallel to one another and a helical tooth portion of one of the first and second helical rotors engages a helical groove of another of the first and second helical rotors, such that the first and second helical rotors are operative to rotate within the chamber and provide fluid transport between the first and second ports parallel to the longitudinal axes. A respective one of the first and second helical rotors has a first tooth surface lying within the helical groove and extending onto the helical tooth portion and a second tooth surface extending from the cylindrical body portion onto the helical tooth portion opposite the first tooth surface. The first tooth surface preferably includes an epitrochoid-derived surface, i.e., a surface defining an epitrochoid curve in radial cross section. The second tooth surface preferably includes an epicycloid-derived surface, i.e., a surface defining an epicycloid curve in radial cross section.
    • 流体位移设备包括在其中限定其中具有第一端口和第二端口的壳体的壳体。 具有相对间距的第一和第二螺旋转子在室内啮合,与第一和第二端口流体连通。 第一和第二螺旋转子中的相应一个包括在其中具有螺旋槽的圆柱形主体部分和从邻近螺旋槽的圆柱形主体部分径向延伸的螺旋齿部分。 第一和第二螺旋转子被布置成使得第一和第二螺旋转子的相应纵向轴线彼此平行,并且第一和第二螺旋转子之一的螺旋齿部分接合第一和第二螺旋转子中的另一个的螺旋槽 螺旋转子,使得第一和第二螺旋转子可操作以在腔室内旋转并且在平行于纵向轴线的第一和第二端口之间提供流体输送。 第一和第二螺旋转子中的相应一个具有位于螺旋槽内并延伸到螺旋齿部分上的第一齿面和从圆柱体部分延伸到与第一齿面相对的螺旋齿部分上的第二齿面。 第一齿表面优选地包括表皮生物衍生表面,即在径向横截面中限定外旋体曲线的表面。 第二牙齿表面优选地包括来自外周血源的表面,即在径向横截面中限定外周血曲线的表面。